All in: Novartis adds another drug to its fast-growing radiopharmaceuticals division
Novartis $NVS has struck the latest in a series of deals to beef up its radiopharmaceuticals group.
Just weeks after the pharma giant …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
